Evaluation of the acute and oral toxicity of ethanol extract from Valeriana pavonii species in Wistar

SUMMARY Introduction : One of the most frequent problems found in medicinal plants is the absence of clinical, toxicological, and pharmacological studies. Valeriana pavonii is one of the species used in Colombia as an anxiolytic. Further study of this specie is rendered to add information in the toxicological area. Objective : The acute and subchronic oral toxicity of V. pavonii ethanolic extract was evaluated in Wistar rats of both sexes. Materials and methods : The rats were distributed into four groups: the control group received the vehicle (0.5 mL/100 g of corporal weight) and the other three groups received increasing levels of the dosage for 90 days to evaluate characteristics like physical exam, laboratory test (blood chemistry and haematology), and anatomopathological findings. Results: This study reveals that there were no signs of toxicity, mortality, or significant alterations attributable to the ethanolic extract of V. pavonii. Conclusions: The Not Observed Adverse Effect Levels (NOAEL) of V. pavonii ethanolic extract were 2000 and 1000 mg/ kg of body weight for the acute and subchronic toxicity studies, respectively.

[1]  J. Rincón,et al.  Isovaleramida, principio anticonvulsivo aislado de Valeriana pavonii , 2010 .

[2]  P. Brown-Woodman,et al.  A developmental toxicity-screening test of valerian. , 2007, Journal of ethnopharmacology.

[3]  J. Rincón,et al.  Actividad farmacológica sobre el sistema nervioso central del extracto etanólico y de la fracción alcaloidal de Valeriana pavonii , 2007 .

[4]  A. Argentino-Storino,et al.  Clinical chemistry and haematology historical data in control Sprague-Dawley rats from pre-clinical toxicity studies. , 2006, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[5]  M. Suckow,et al.  The laboratory rat , 2006 .

[6]  Alexis Bermúdez,et al.  La investigación etnobotánica sobre plantas medicinales: una revisión de sus objetivos y enfoques actuales. , 2005 .

[7]  R. Herrera,et al.  Estudios etnobotánicos sobre plantas medicinales en la provincia de Camagüey (Cuba) , 2004 .

[8]  W. Schill Applied Longitudinal Data Analysis for Epidemiology: A Practical Guide. , 2004 .

[9]  M. Thrall Veterinary Hematology and Clinical Chemistry , 2003 .

[10]  J. Medina,et al.  6-Methylapigenin and hesperidin: new valeriana flavonoids with activity on the CNS , 2003, Pharmacology Biochemistry and Behavior.

[11]  P. Grasso Essentials of Pathology for Toxicologists , 2002 .

[12]  M. Osorio Estrategia de la OMS sobre Medicina Tradicional 2002-2005 , 2002 .

[13]  E. Ernst,et al.  Valerian for insomnia: a systematic review of randomized clinical trials. , 2000, Sleep medicine.

[14]  J. Menke Herbal remedies. , 1997, South Dakota journal of medicine.

[15]  V. Moser,et al.  A multidisciplinary approach to toxicological screening: III. Neurobehavioral toxicity. , 1995, Journal of toxicology and environmental health.

[16]  B. T. Bennett,et al.  Essentials for animal research. A primer for research personnel. , 1990 .